Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans

Jielin Sun, Lina Purcell, Zhengrong Gao, Sarah D. Isaacs, Kathleen E. Wiley, Fang Chi Hsu, Wennuan Liu, David Duggan, John D. Carpten, Henrik Grönberg, Jianfeng Xu, Bao Li Chang, Alan Wayne Partin, Patrick Walsh, William B Isaacs, S. Lilly Zheng

Research output: Contribution to journalArticle

Abstract

BACKGROUND. Three SNPs at 17q12 and four SNPs at 17q24.3 were recently identified to be associated with prostate cancer risk using a genome-wide association study. METHODS. We evaluated these 7 SNPs in two hospital-based case-control study populations, including European Americans (EA; 1,563 cases and 576 controls) and African Americans (AA; 364 cases and 353 controls). RESULTS. Each of the reported risk alleles of these seven SNPs were more common in cases than in controls among EA and AA. The differences were highly significant in EA (P = 10-4) and marginally significant in AA (P = 0.04) for SNPs at 17q12. In contrast, the differences were not statistically significant in EA or AA for SNPs at 17q24.3, but were marginally significant for two SNPs (P = 0.04-0.06) when EA and AA subjects were combined. Similar results were obtained when genotype and haplotype frequencies between cases and controls were analyzed. These risk variants were not associated with more aggressive prostate cancer or other clinical variables such as TNM stage, pre-operative PSA, or age at diagnosis. CONCLUSIONS. Results from our study provide the first confirmation of these 17q SNPs as novel prostate cancer susceptibility loci in EA and the first indication that these two loci may also play roles in prostate cancer risk among AA.

Original languageEnglish (US)
Pages (from-to)691-697
Number of pages7
JournalProstate
Volume68
Issue number7
DOIs
StatePublished - May 15 2008

Fingerprint

African Americans
Single Nucleotide Polymorphism
Prostatic Neoplasms
Genome-Wide Association Study
Haplotypes
Case-Control Studies
Alleles
Genotype
Population

Keywords

  • 17q12
  • 17q24.3
  • Association
  • Prostate cancer
  • Risk

ASJC Scopus subject areas

  • Urology

Cite this

Sun, J., Purcell, L., Gao, Z., Isaacs, S. D., Wiley, K. E., Hsu, F. C., ... Zheng, S. L. (2008). Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate, 68(7), 691-697. https://doi.org/10.1002/pros.20754

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. / Sun, Jielin; Purcell, Lina; Gao, Zhengrong; Isaacs, Sarah D.; Wiley, Kathleen E.; Hsu, Fang Chi; Liu, Wennuan; Duggan, David; Carpten, John D.; Grönberg, Henrik; Xu, Jianfeng; Chang, Bao Li; Partin, Alan Wayne; Walsh, Patrick; Isaacs, William B; Zheng, S. Lilly.

In: Prostate, Vol. 68, No. 7, 15.05.2008, p. 691-697.

Research output: Contribution to journalArticle

Sun, J, Purcell, L, Gao, Z, Isaacs, SD, Wiley, KE, Hsu, FC, Liu, W, Duggan, D, Carpten, JD, Grönberg, H, Xu, J, Chang, BL, Partin, AW, Walsh, P, Isaacs, WB & Zheng, SL 2008, 'Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans', Prostate, vol. 68, no. 7, pp. 691-697. https://doi.org/10.1002/pros.20754
Sun, Jielin ; Purcell, Lina ; Gao, Zhengrong ; Isaacs, Sarah D. ; Wiley, Kathleen E. ; Hsu, Fang Chi ; Liu, Wennuan ; Duggan, David ; Carpten, John D. ; Grönberg, Henrik ; Xu, Jianfeng ; Chang, Bao Li ; Partin, Alan Wayne ; Walsh, Patrick ; Isaacs, William B ; Zheng, S. Lilly. / Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. In: Prostate. 2008 ; Vol. 68, No. 7. pp. 691-697.
@article{3a4610b243ef40c98ef5c14ec6aeef0d,
title = "Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans",
abstract = "BACKGROUND. Three SNPs at 17q12 and four SNPs at 17q24.3 were recently identified to be associated with prostate cancer risk using a genome-wide association study. METHODS. We evaluated these 7 SNPs in two hospital-based case-control study populations, including European Americans (EA; 1,563 cases and 576 controls) and African Americans (AA; 364 cases and 353 controls). RESULTS. Each of the reported risk alleles of these seven SNPs were more common in cases than in controls among EA and AA. The differences were highly significant in EA (P = 10-4) and marginally significant in AA (P = 0.04) for SNPs at 17q12. In contrast, the differences were not statistically significant in EA or AA for SNPs at 17q24.3, but were marginally significant for two SNPs (P = 0.04-0.06) when EA and AA subjects were combined. Similar results were obtained when genotype and haplotype frequencies between cases and controls were analyzed. These risk variants were not associated with more aggressive prostate cancer or other clinical variables such as TNM stage, pre-operative PSA, or age at diagnosis. CONCLUSIONS. Results from our study provide the first confirmation of these 17q SNPs as novel prostate cancer susceptibility loci in EA and the first indication that these two loci may also play roles in prostate cancer risk among AA.",
keywords = "17q12, 17q24.3, Association, Prostate cancer, Risk",
author = "Jielin Sun and Lina Purcell and Zhengrong Gao and Isaacs, {Sarah D.} and Wiley, {Kathleen E.} and Hsu, {Fang Chi} and Wennuan Liu and David Duggan and Carpten, {John D.} and Henrik Gr{\"o}nberg and Jianfeng Xu and Chang, {Bao Li} and Partin, {Alan Wayne} and Patrick Walsh and Isaacs, {William B} and Zheng, {S. Lilly}",
year = "2008",
month = "5",
day = "15",
doi = "10.1002/pros.20754",
language = "English (US)",
volume = "68",
pages = "691--697",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans

AU - Sun, Jielin

AU - Purcell, Lina

AU - Gao, Zhengrong

AU - Isaacs, Sarah D.

AU - Wiley, Kathleen E.

AU - Hsu, Fang Chi

AU - Liu, Wennuan

AU - Duggan, David

AU - Carpten, John D.

AU - Grönberg, Henrik

AU - Xu, Jianfeng

AU - Chang, Bao Li

AU - Partin, Alan Wayne

AU - Walsh, Patrick

AU - Isaacs, William B

AU - Zheng, S. Lilly

PY - 2008/5/15

Y1 - 2008/5/15

N2 - BACKGROUND. Three SNPs at 17q12 and four SNPs at 17q24.3 were recently identified to be associated with prostate cancer risk using a genome-wide association study. METHODS. We evaluated these 7 SNPs in two hospital-based case-control study populations, including European Americans (EA; 1,563 cases and 576 controls) and African Americans (AA; 364 cases and 353 controls). RESULTS. Each of the reported risk alleles of these seven SNPs were more common in cases than in controls among EA and AA. The differences were highly significant in EA (P = 10-4) and marginally significant in AA (P = 0.04) for SNPs at 17q12. In contrast, the differences were not statistically significant in EA or AA for SNPs at 17q24.3, but were marginally significant for two SNPs (P = 0.04-0.06) when EA and AA subjects were combined. Similar results were obtained when genotype and haplotype frequencies between cases and controls were analyzed. These risk variants were not associated with more aggressive prostate cancer or other clinical variables such as TNM stage, pre-operative PSA, or age at diagnosis. CONCLUSIONS. Results from our study provide the first confirmation of these 17q SNPs as novel prostate cancer susceptibility loci in EA and the first indication that these two loci may also play roles in prostate cancer risk among AA.

AB - BACKGROUND. Three SNPs at 17q12 and four SNPs at 17q24.3 were recently identified to be associated with prostate cancer risk using a genome-wide association study. METHODS. We evaluated these 7 SNPs in two hospital-based case-control study populations, including European Americans (EA; 1,563 cases and 576 controls) and African Americans (AA; 364 cases and 353 controls). RESULTS. Each of the reported risk alleles of these seven SNPs were more common in cases than in controls among EA and AA. The differences were highly significant in EA (P = 10-4) and marginally significant in AA (P = 0.04) for SNPs at 17q12. In contrast, the differences were not statistically significant in EA or AA for SNPs at 17q24.3, but were marginally significant for two SNPs (P = 0.04-0.06) when EA and AA subjects were combined. Similar results were obtained when genotype and haplotype frequencies between cases and controls were analyzed. These risk variants were not associated with more aggressive prostate cancer or other clinical variables such as TNM stage, pre-operative PSA, or age at diagnosis. CONCLUSIONS. Results from our study provide the first confirmation of these 17q SNPs as novel prostate cancer susceptibility loci in EA and the first indication that these two loci may also play roles in prostate cancer risk among AA.

KW - 17q12

KW - 17q24.3

KW - Association

KW - Prostate cancer

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=43049102789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049102789&partnerID=8YFLogxK

U2 - 10.1002/pros.20754

DO - 10.1002/pros.20754

M3 - Article

C2 - 18361410

AN - SCOPUS:43049102789

VL - 68

SP - 691

EP - 697

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 7

ER -